Trial Profile
A Study of efficacy of Tolvaptan for Patients with Chronic Heart Failure
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2013
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- 08 Feb 2013 New trial record
- 01 Feb 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.